<?xml version="1.0" encoding="UTF-8"?><!-- generator="podbean/5.5" -->
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:wfw="http://wellformedweb.org/CommentAPI/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
     xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
     xmlns:spotify="http://www.spotify.com/ns/rss"
     xmlns:podcast="https://podcastindex.org/namespace/1.0"
    xmlns:media="http://search.yahoo.com/mrss/">

<channel>
    <title>On Target Podcast</title>
    <atom:link href="https://feed.podbean.com/ontargetpodcast/feed.xml" rel="self" type="application/rss+xml"/>
    <link>https://ontargetpodcast.com</link>
    <description><![CDATA[<div id="bgLayers_comp-miqcx14j1" class="MW5IWV">
<div id="bgMedia_comp-miqcx14j1" class="VgO9Yg"></div>
</div>
<div>
<div>
<div id="comp-miqcx14l" class="Z_l5lU ku3DBC zQ9jDz qvSjx3 Vq6kJx comp-miqcx14l wixui-rich-text">
<p class="font_7 wixui-rich-text__text">On Target: Targeting What Matters in Testing is a podcast dedicated to exploring the evolving landscape of diagnostics and its critical role in the development of precision healthcare. Testing is at the center of healthcare like never before, thanks to advancements in genomic sequencing, AI-driven diagnostics, biomarker-driven therapies, and home testing. Healthcare systems are adapting to integrate these technologies effectively, and regulators are trying to keep pace with innovation.  </p>
<p class="font_7 wixui-rich-text__text"><span class="wixGuard wixui-rich-text__text">​</span></p>
<p class="font_7 wixui-rich-text__text">Co-hosted by industry experts, On Target features conversations with testing company and laboratory executives, innovators, and thought leaders who are shaping the future of healthcare through testing products and services. </p>
<p class="font_7 wixui-rich-text__text">In the time it takes to drink your coffee, we'll let you know where the field is going next.</p>
</div>
</div>
</div>]]></description>
    <pubDate>Tue, 12 May 2026 11:57:00 -0700</pubDate>
    <generator>https://podbean.com/?v=5.5</generator>
    <language>en</language>
        <copyright>Copyright 2026 All rights reserved.</copyright>
    <category>News</category>
    <ttl>1440</ttl>
    <itunes:type>episodic</itunes:type>
          <itunes:summary>On Target: Targeting What Matters in Testing is a podcast dedicated to exploring the evolving landscape of diagnostics and its critical role in the development of precision healthcare. Testing is at the center of healthcare like never before, thanks to advancements in genomic sequencing, AI-driven diagnostics, biomarker-driven therapies, and home testing. Healthcare systems are adapting to integrate these technologies effectively, and regulators are trying to keep pace with innovation.  

​
Co-hosted by industry experts, On Target features conversations with testing company and laboratory executives, innovators, and thought leaders who are shaping the future of healthcare through testing products and services. 

In the time it takes to drink your coffee, we’ll let you know where the field is going next.</itunes:summary>
        <itunes:author>On Target Podcast</itunes:author>
<itunes:category text="News" />
	<itunes:category text="Health &amp; Fitness">
		<itunes:category text="Medicine" />
	</itunes:category>
    <itunes:owner>
        <itunes:name>On Target Podcast</itunes:name>
            </itunes:owner>
    	<itunes:block>No</itunes:block>
	<itunes:explicit>false</itunes:explicit>
	<itunes:new-feed-url>https://feed.podbean.com/ontargetpodcast/feed.xml</itunes:new-feed-url>
    <itunes:image href="https://pbcdn1.podbean.com/imglogo/image-logo/21883636/OTP_Logoailck.jpg" />
    <image>
        <url>https://pbcdn1.podbean.com/imglogo/image-logo/21883636/OTP_Logoailck.jpg</url>
        <title>On Target Podcast</title>
        <link>https://ontargetpodcast.com</link>
        <width>144</width>
        <height>144</height>
    </image>
    <item>
        <title>Identifying hard-to-diagnose infections in cancer patients  - On Target Podcast w/ Alec Ford, CEO, Karius</title>
        <itunes:title>Identifying hard-to-diagnose infections in cancer patients  - On Target Podcast w/ Alec Ford, CEO, Karius</itunes:title>
        <link>https://ontargetpodcast.podbean.com/e/identifying-hard-to-diagnose-infections-in-cancer-patients-on-target-podcast-w-alec-ford-ceo-karius/</link>
                    <comments>https://ontargetpodcast.podbean.com/e/identifying-hard-to-diagnose-infections-in-cancer-patients-on-target-podcast-w-alec-ford-ceo-karius/#comments</comments>        <pubDate>Tue, 12 May 2026 11:57:00 -0700</pubDate>
        <guid isPermaLink="false">ontargetpodcast.podbean.com/c12f047a-8425-3930-aa71-33122aed7125</guid>
                                    <description><![CDATA[<p>Alec Ford, CEO of Karius, shares how genomics and AI are expanding what's possible in infectious disease diagnostics — and why getting the right answer faster can make all the difference for immunocompromised patients battling cancer and other serious conditions.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Alec Ford, CEO of Karius, shares how genomics and AI are expanding what's possible in infectious disease diagnostics — and why getting the right answer faster can make all the difference for immunocompromised patients battling cancer and other serious conditions.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4jfz2exemf54rgxc/Alec_Ford_Karius_Podcast_7yawc.mp3" length="40341965" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Alec Ford, CEO of Karius, shares how genomics and AI are expanding what's possible in infectious disease diagnostics — and why getting the right answer faster can make all the difference for immunocompromised patients battling cancer and other serious conditions.]]></itunes:summary>
        <itunes:author>On Target Podcast</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1680</itunes:duration>
                <itunes:episode>7</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog21883636/THUMBNAILS_6_7ef4s.png" />    </item>
    <item>
        <title>Advancing multiple-myeloma and blood-cancer dx with WGS  - On Target Podcast w/ Irene Ghobrial, Co-Founder, Predicta Biosciences</title>
        <itunes:title>Advancing multiple-myeloma and blood-cancer dx with WGS  - On Target Podcast w/ Irene Ghobrial, Co-Founder, Predicta Biosciences</itunes:title>
        <link>https://ontargetpodcast.podbean.com/e/advancing-multiple-myeloma-and-blood-cancer-dx-with-wgs-on-target-podcast-w-irene-ghobrial-co-founder-predicta-biosciences/</link>
                    <comments>https://ontargetpodcast.podbean.com/e/advancing-multiple-myeloma-and-blood-cancer-dx-with-wgs-on-target-podcast-w-irene-ghobrial-co-founder-predicta-biosciences/#comments</comments>        <pubDate>Tue, 28 Apr 2026 01:51:00 -0700</pubDate>
        <guid isPermaLink="false">ontargetpodcast.podbean.com/512c43b8-8370-380f-8a69-dc246c09dc38</guid>
                                    <description><![CDATA[<p>Irene Ghobrial, founder of Predicta Biosciences, explains how bringing whole-genome sequencing into the clinic is taking diagnosis and treatment of multiple myeloma and blood cancers to a new level of precision.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Irene Ghobrial, founder of Predicta Biosciences, explains how bringing whole-genome sequencing into the clinic is taking diagnosis and treatment of multiple myeloma and blood cancers to a new level of precision.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ridm25cfdg8rheen/Irene_Ghobrial_Predicta_Podcast_aebl5.mp3" length="39024139" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Irene Ghobrial, founder of Predicta Biosciences, explains how bringing whole-genome sequencing into the clinic is taking diagnosis and treatment of multiple myeloma and blood cancers to a new level of precision.]]></itunes:summary>
        <itunes:author>On Target Podcast</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1625</itunes:duration>
                <itunes:episode>6</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog21883636/THUMBNAILS_1_6heoq.png" />    </item>
    <item>
        <title>"Expanding genomic analysis with optical genome mapping  - On Target Podcast w/ Alka Chaubey CMO, Bionano Genomics"</title>
        <itunes:title>"Expanding genomic analysis with optical genome mapping  - On Target Podcast w/ Alka Chaubey CMO, Bionano Genomics"</itunes:title>
        <link>https://ontargetpodcast.podbean.com/e/expanding-genomic-analysis-with-optical-genome-mapping-on-target-podcast-w-alka-chaubey-cmo-bionano-genomics/</link>
                    <comments>https://ontargetpodcast.podbean.com/e/expanding-genomic-analysis-with-optical-genome-mapping-on-target-podcast-w-alka-chaubey-cmo-bionano-genomics/#comments</comments>        <pubDate>Tue, 14 Apr 2026 01:50:00 -0700</pubDate>
        <guid isPermaLink="false">ontargetpodcast.podbean.com/271f4259-6190-3dab-8783-a185ef4e5db2</guid>
                                    <description><![CDATA[<p>Alka Chaubey, CMO of Bionano Genomics, explains how optical genome mapping addresses the unmet needs of cytogenomics - and what it takes to get pathbreaking new technology into the clinic.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Alka Chaubey, CMO of Bionano Genomics, explains how optical genome mapping addresses the unmet needs of cytogenomics - and what it takes to get pathbreaking new technology into the clinic.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ax79vm28ykftqyar/Alka_Chaubey_BioNano_Podcast_a6tqb.mp3" length="33888257" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Alka Chaubey, CMO of Bionano Genomics, explains how optical genome mapping addresses the unmet needs of cytogenomics - and what it takes to get pathbreaking new technology into the clinic.]]></itunes:summary>
        <itunes:author>On Target Podcast</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1411</itunes:duration>
                <itunes:episode>5</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog21883636/THUMBNAILS_3_8nlsz.png" />    </item>
    <item>
        <title>Using fragmentomics for early cancer detection - On Target Podcast w/ Susan Tousi CEO of Delfi</title>
        <itunes:title>Using fragmentomics for early cancer detection - On Target Podcast w/ Susan Tousi CEO of Delfi</itunes:title>
        <link>https://ontargetpodcast.podbean.com/e/using-fragmentomics-for-early-cancer-detection-on-target-podcast-w-susan-tousi-ceo-of-delfi/</link>
                    <comments>https://ontargetpodcast.podbean.com/e/using-fragmentomics-for-early-cancer-detection-on-target-podcast-w-susan-tousi-ceo-of-delfi/#comments</comments>        <pubDate>Tue, 31 Mar 2026 14:36:55 -0700</pubDate>
        <guid isPermaLink="false">ontargetpodcast.podbean.com/b4e939d9-299c-3f01-b904-a8391a4d9601</guid>
                                    <description><![CDATA[<p>Susan Tousi, CEO of DELFI Diagnostics, shares how her company is using AI and fragmentomics to make liquid biopsy more accessible and cancer less deadly.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Susan Tousi, CEO of DELFI Diagnostics, shares how her company is using AI and fragmentomics to make liquid biopsy more accessible and cancer less deadly.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/swmty9ge5hyc65vm/Delfi_Susan_Tousi_Podcast7l30x.mp3" length="64094794" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Susan Tousi, CEO of DELFI Diagnostics, shares how her company is using AI and fragmentomics to make liquid biopsy more accessible and cancer less deadly.]]></itunes:summary>
        <itunes:author>On Target Podcast</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2670</itunes:duration>
                <itunes:episode>4</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog21883636/THUMBNAILS_2_bj4kx.png" />    </item>
    <item>
        <title>Integrating genomics into standard patient care - On Target Podcast w/ James Lu Co-Founder and CEO of Helix</title>
        <itunes:title>Integrating genomics into standard patient care - On Target Podcast w/ James Lu Co-Founder and CEO of Helix</itunes:title>
        <link>https://ontargetpodcast.podbean.com/e/integrating-genomics-into-standard-patient-care/</link>
                    <comments>https://ontargetpodcast.podbean.com/e/integrating-genomics-into-standard-patient-care/#comments</comments>        <pubDate>Wed, 18 Mar 2026 19:38:00 -0700</pubDate>
        <guid isPermaLink="false">ontargetpodcast.podbean.com/5b903b74-4b0e-38b3-bdc0-128d722aea6d</guid>
                                    <description><![CDATA[<p>James Lu, co-founder and CEO of Helix, tells us what his company is doing to make genomics part of the standard portfolio of health-care data.
</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>James Lu, co-founder and CEO of Helix, tells us what his company is doing to make genomics part of the standard portfolio of health-care data.<br>
</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/asg9pi4ndaysmkpy/Helix_James_Lu_Podcast_bs5rs.mp3" length="34744028" type="audio/mpeg"/>
        <itunes:summary><![CDATA[James Lu, co-founder and CEO of Helix, tells us what his company is doing to make genomics part of the standard portfolio of health-care data.]]></itunes:summary>
        <itunes:author>On Target Podcast</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1447</itunes:duration>
                <itunes:episode>3</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog21883636/Using_AI_to_predict_breast-cancer_risk_3_7y5v4.png" />    </item>
    <item>
        <title>Expanding consumer-directed health - On Target Podcast w/ Julia Cheek Founder and CEO of Everlywell</title>
        <itunes:title>Expanding consumer-directed health - On Target Podcast w/ Julia Cheek Founder and CEO of Everlywell</itunes:title>
        <link>https://ontargetpodcast.podbean.com/e/expanding-consumer-directed-health-on-target-podcast-w-julia-cheek-founder-and-ceo-of-everlywell/</link>
                    <comments>https://ontargetpodcast.podbean.com/e/expanding-consumer-directed-health-on-target-podcast-w-julia-cheek-founder-and-ceo-of-everlywell/#comments</comments>        <pubDate>Wed, 04 Mar 2026 17:18:53 -0700</pubDate>
        <guid isPermaLink="false">ontargetpodcast.podbean.com/8879c0e5-35e5-3ae5-913e-0fa5d8cfa681</guid>
                                    <description><![CDATA[<p>Julia Cheek, founder and CEO of Everlywell, shares how her company is working to change not only the way people access, use, and understand home tests, but the way home tests fit into the entire landscape of medicine.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Julia Cheek, founder and CEO of Everlywell, shares how her company is working to change not only the way people access, use, and understand home tests, but the way home tests fit into the entire landscape of medicine.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iy8eapkmscjwsdk8/Everlywell_Julia_Cheek_Podcast839xh.mp3" length="40556378" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Julia Cheek, founder and CEO of Everlywell, shares how her company is working to change not only the way people access, use, and understand home tests, but the way home tests fit into the entire landscape of medicine.]]></itunes:summary>
        <itunes:author>On Target Podcast</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1689</itunes:duration>
                <itunes:episode>2</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog21883636/Using_AI_to_predict_breast-cancer_risk_4_ai0e2.png" />    </item>
    <item>
        <title>Rapid genomic sequencing for rare diseases - On Target Podcast w/ Katherine Stueland CEO of GeneDx</title>
        <itunes:title>Rapid genomic sequencing for rare diseases - On Target Podcast w/ Katherine Stueland CEO of GeneDx</itunes:title>
        <link>https://ontargetpodcast.podbean.com/e/rapid-genomic-sequencing-for-rare-diseases/</link>
                    <comments>https://ontargetpodcast.podbean.com/e/rapid-genomic-sequencing-for-rare-diseases/#comments</comments>        <pubDate>Sun, 15 Feb 2026 11:06:35 -0700</pubDate>
        <guid isPermaLink="false">ontargetpodcast.podbean.com/422b11e1-94e8-39ff-aff2-8a24832f02c1</guid>
                                    <description><![CDATA[<p>Katherine Stueland, CEO of GeneDx, shares how her company is scaling whole-genome and exome sequencing for the diagnosis of rare diseases.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Katherine Stueland, CEO of GeneDx, shares how her company is scaling whole-genome and exome sequencing for the diagnosis of rare diseases.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4fx2jur9netzieb7/GeneDex_Podcast9p53o.mp3" length="48475241" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Katherine Stueland, CEO of GeneDx, shares how her company is scaling whole-genome and exome sequencing for the diagnosis of rare diseases.]]></itunes:summary>
        <itunes:author>On Target Podcast</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2019</itunes:duration>
                <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog21883636/genedx.png" />    </item>
</channel>
</rss>
